NEWS
Our Latest News
ARCHIMED purchases BioVendor Group, a leading global player in advanced diagnostics
Global private equity healthcare specialist ARCHIMED announces the acquisition of BioVendor Group, a major player in advanced diagnostics, with expertise in immunology, infectious, metabolic, and autoimmune diseases as well as genetics research, expanding ARCHIMED’s numerous investments in the diagnostics industry.
ARCHIMED’s Direct Healthcare Group buys United Care BV
March
24,
2021
ARCHIMED’s Direct Healthcare Group acquires Talley
March
3,
2021
Acquisition by ARCHIMED’s NAMSA makes it the preeminent contract research organization for medtech lab testing
March
2,
2021
ARCHIMED strengthens its North American capabilities
January
26,
2021
368